What We Know About Hantavirus?

 Hantavirus is a family of viruses that can cause severe, life-threatening illnesses in humans. Though relatively rare, these rodent-borne pathogens have captured public attention due to their high fatality rates and unpredictable outbreaks. First identified in the 1950s near the Hantaan River in Korea (giving the virus its name), hantaviruses continue to pose risks worldwide, particularly in rural and wilderness areas where humans encounter infected rodents(WHO)

Where It Comes From: Origins and Transmission?

Hantaviruses originate in specific rodent species, with each virus typically tied to one primary host. For example:

• In North America, the deer mouse (Peromyscus maniculatus) carries Sin Nombre virus, the most common cause of HPS in the United States.
• Other rodents, such as cotton rats, rice rats, and white-footed mice, harbor different strains.
• In Europe and Asia, bank voles, field mice, and rats transmit viruses like Puumala, Hantaan, Dobrava, and Seoul.(CDC)

Other rodents, such as cotton rats, rice rats, and white-footed mice, harbor different strains.

In Europe and Asia, bank voles, field mice, and rats transmit viruses like Puumala, Hantaan, Dobrava, and Seoul.

How It Affects Humans

After exposure, symptoms usually appear 1–8 weeks later (most often 1–2 weeks). Early signs mimic the flu: fever, fatigue, muscle aches (especially in large muscles like thighs, hips, and back), headache, dizziness, chills, and gastrointestinal issues such as nausea, vomiting, or abdominal pain.(CDC)

The disease then diverges by syndrome:

• HPS (Americas): After the initial phase, patients rapidly develop severe respiratory distress. Coughing and shortness of breath emerge as fluid fills the lungs, leading to chest tightness, low blood pressure, and potential shock or heart failure. Without intensive intervention, this can progress to respiratory collapse within days.
• HFRS (Europe/Asia): Later stages involve low blood pressure, internal bleeding, vascular leakage, and acute kidney failure (with reduced urine output, fluid overload, and sometimes blood in the urine). Additional symptoms may include blurred vision, flushed face, rash, or eye inflammation.(WHO)

Laboratory findings often show low platelets, elevated white blood cells, and hemoconcentration. The virus triggers an overactive immune response that damages blood vessels and organs rather than direct viral destruction.

Treatments

There is no specific antiviral drug or vaccine licensed for hantavirus infections. Treatment is entirely supportive and focuses on keeping patients alive until their immune system clears the virus. Early hospitalization in an intensive care unit (ICU) dramatically improves outcomes. (WHO)

• For HPS: Oxygen therapy, mechanical ventilation (intubation), intravenous fluids, and medications to stabilize blood pressure and heart function are critical. Extracorporeal membrane oxygenation (ECMO) may be used in the most severe cases.
• For HFRS: Dialysis is often required to manage kidney failure and fluid balance.

The antiviral drug ribavirin has shown some benefit in treating certain HFRS strains when given early, but it is not routinely recommended for HPS and lacks strong evidence of efficacy against New World hantaviruses. Recovery can take weeks to months, with lingering fatigue common.(CDC)

Estimated Deaths

Hantavirus carries a high case-fatality rate that varies by region and virus type:

• HPS in the Americas: Approximately 20–40% (CDC data indicate 38% of patients who develop respiratory symptoms die). In the U.S., where about 890 cases have been reported since surveillance began in 1993, roughly 35% have been fatal. (CDC)
• HFRS in Europe and Asia: Generally lower, ranging from <1% (e.g., Puumala virus) to 5–15% (e.g., Hantaan or Dobrava viruses). (WHO) 

Globally, experts estimate 10,000 to over 100,000 infections occur annually, with the heaviest burden in Asia (especially China) and Europe. The Americas see far fewer cases—hundreds per year—but the higher lethality makes HPS a significant concern. In the U.S., cases average fewer than 30 per year, mostly in western states. (WHO)

While outbreaks remain sporadic, recent events, like a 2026 Andes virus cluster linked to a cruise ship—highlight the virus’s potential for international spread under unusual circumstances. Most cases, however, stem from everyday rodent encounters in homes or workplaces.

Prevention Methods

Seal homes against rodents, store food securely, use gloves and masks when cleaning droppings (dampen them first to avoid aerosols), and avoid rodent-infested areas. Public health officials stress that awareness and rodent control are key to minimizing risk.

Hantavirus serves as a stark reminder of humanity’s close relationship with wildlife. Though rare, its potential for rapid progression demands respect for the wild rodents that share our environments. (WHO)